Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update for certolizumab pegol in adult-onset active and progressive psoriatic arthritis has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
A completed clinical trial evaluating pain management in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis patients who …
-
FDA approval · 2014-01-16FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for cyclosporine from Apotex Corp, authorizing changes under the generic product's regulatory fi…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Impact of Literacy Level on Patient Education and Health Among People With Arthritis [Phase 2]
This Phase 2 trial update examines how literacy level influences patient education and health outcomes in people with arthritis, including r…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
This completed clinical trial update examines how antirheumatic treatment affects endothelial function, inflammatory disease activity, and b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial of Onercept for moderate to severe plaque psoriasis, including treatment and re-treatment, has been terminated.
-
FDA approval · 2013-10-11FDA Approved: OTREXUP — Original Application (Antares Pharma, Inc.)
FDA approved OTREXUP, a subcutaneous methotrexate injection from Antares Pharma, under an original NDA for autoimmune conditions including r…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)
AbbVie-sponsored special investigation in patients with psoriasis vulgaris and psoriatic arthritis completed; results were posted in 2013.
-
CLINICAL_TRIALS research · 2013-09-11Clinical Trial Update: Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis [Phase 4]
This document describes a Phase 4 clinical trial protocol evaluating Acthar Gel (adrenocorticotropic hormone) for moderately to severely act…
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Surveillance of Humira Injection in Korean Patients
Results from a completed clinical trial evaluating Humira (adalimumab) in Korean patients with rheumatoid arthritis, psoriatic arthritis, an…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA
A completed post-marketing surveillance study of etanercept (Enbrel) evaluating its real-world use in rheumatoid arthritis and psoriatic art…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
An observational study update on infliximab use in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis, and psoriasis, with th…
-
CLINICAL_TRIALS research · 2013-07-03Clinical Trial Update: to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish
This clinical trial update covers the translation and validation of the Toronto Psoriatic Arthritis Screening Questionnaire (TOPAS) into Spa…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis
Clinical trial update on etanercept in adults with psoriatic arthritis reports safety and adherence findings, with results posted in 2013.
-
FDA approval · 2013-05-15FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi (golimumab) from Janssen Biotech, Inc., expanding the labeling for the product.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Enbrel® in Psoriatic Arthritis [Phase 4]
Phase 4 trial of Enbrel (etanercept) for psoriatic arthritis has completed (sponsor: Amgen).
-
FDA approval · 2013-04-29FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab from Janssen Biotech, expanding its labeling and indications.
-
FDA approval · 2013-04-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Functional Limitations Due To The Foot Involvement In Spondyloarthritis
A completed clinical trial evaluating how foot involvement affects functional limitations in patients with ankylosing spondylitis and psoria…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
A completed clinical trial evaluating Humira (adalimumab) in active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in…
-
FDA approval · 2013-02-05FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for methotrexate, enabling the marketing of a generic methotrexate product…
-
FDA approval · 2013-01-25FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc.
-
FDA approval · 2012-12-10FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Web-based Support to Manage Arthritis Pain [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a web-based tool to help manage arthritis pain.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
This clinical trial update reports demographics, compliance, tolerability, and safety data for patients with rheumatoid arthritis, psoriatic…